Project Grant R01DK141169

Award Date 8/1/24
Completion Date 5/31/28
Dollars Obligated $1M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
This is a Project Grant awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, totaling $1,630,964.00, was awarded to the University of Southern California (USC) on September 15, 2024 with a completion date of July 31, 2029. The project aims to study the dynamic spatial configuration of hematopoietic stem and progenitor cells (HSPCs) during blood and immune cell regeneration in the bone marrow. The...
This $225,306 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports a collaborative research project between researchers at the University of Southern California (USC) and a German partner to investigate the long-term impact of early-life growth signals on adult hematopoietic (blood) stem cell function and selection. The key products and services to be delivered under this 3-year award include: 1) using stem cell transplantation and...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $734,607 to Boston Medical Center Corporation (BMC) to elucidate the key endothelial mechanisms that facilitate the trans-endothelial migration of hematopoietic stem cells (HSCs) into their bone marrow niches. The 5-year project aims to define the endothelial receptor domains, binding partners, and vascular endocytosis/membrane...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $792,498 to the Trustees of Indiana University, Indianapolis (IU Indianapolis) to conduct research on hematopoietic stem cells (HSCs) and their regulation under low oxygen tension (hypoxia). The primary goals are to: 1) understand how hypoxia activates the transcription factor TFE3 to facilitate HSC self-renewal, 2) determine...
This $249,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to elucidate the molecular mechanisms controlling hematopoietic stem cell (HSC) fate choices, including symmetric self-renewal, symmetric commitment, and asymmetric divisions. The research aims to characterize the HSC-like intermediate state controlled by m6A RNA...
This $677,600 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to gain a mechanistic understanding of erythroid progenitor (EP) self-renewal, both in vitro and in vivo. The primary goals are to: Test the hypothesis that the BMI1/RING1B chromatin modulators regulate human self-renewing erythroblast (SRE) self-renewal through epigenetic control of transcription and cholesterol homeostasis. Test the hypothesis that...
This $153,696.00 Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), supports research aimed at elucidating the developmental origins and functional characteristics of myeloid-biased hematopoietic stem cells (HSCs) that emerge during fetal development. The principal investigator at The Leland Stanford Junior University will utilize advanced techniques such as flow cytometry, immunofluorescence, transplantation, and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $153,117 to support a 5-year research project focused on improving hematopoietic stem cell (HSPC) transplantation outcomes. The goal is to investigate mechanisms of HSPC-niche cell crosstalk, specifically how HSPC-derived extracellular vesicles promote remodeling of bone marrow endothelial cells and migration of HSPCs. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,123,357.00 to support research on the bone marrow microenvironment and its role in regulating blood cell production. The research, to be conducted by the Children's Hospital Medical Center in Cincinnati, Ohio, aims to define the spatial organization and specialized vascular microenvironments within the bone marrow that recruit and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $146,876 to the Coriell Institute for Medical Research to develop new methods for expanding functional hematopoietic stem cells (HSCs) from cryopreserved umbilical cord blood (UCB) samples. The project aims to optimize an approach using PPAR-α agonists, which have been shown to significantly expand long-term functional UCB HSCs...

DISSECTING DIVERGENT HEMATOPOIETIC STEM AND PROGENITOR CELL ONTOGENY - DISSECTING DIVERGENT HEMATOPOIETIC STEM AND PROGENITOR CELL ONTOGENY DURING DEVELOPMENT PROJECT ABSTRACT 1 THE HEMATOPOIETIC AND IMMUNE LANDSCAPE IS COMPLEX. THE DIVERSITY IS GENERATED AND SUSTAINED BY THE FUNCTION 2 OF HEMATOPOIETIC STEM CELLS (HSCS) AND PROGENITOR CELLS THAT ARISE INDEPENDENTLY DURING EMBRYONIC DEVELOPMENT. 3 HSCS ARE CHARACTERIZED BY THEIR ROBUST, LIFELONG SELF-RENEWAL ABILITY AND DIFFERENTIATION MULTIPOTENCY, WHILE HSC- 4 INDEPENDENT PROGENITOR CAPACITIES AND LIFESPANS ARE MORE LIMITED. HSC AND HSC-INDEPENDENT DERIVED PROGENY 5 CAN HAVE DISTINCTIVE FUNCTIONS WITH DEFECTS IN THE CELLS RESULTING IN DIFFERENT DISEASE STATES. THEIR IMPORTANT AND 6 UNIQUE PROPERTIES ARE INHERENT AND PROGRAMMED DURING ONTOGENY. CURRENTLY, THE FUNCTIONAL DIFFERENCES BETWEEN 7 HSCS AND HSC-INDEPENDENT PROGENITORS ARE LARGELY DISSECTED WITH ASSAYS THAT REQUIRE THE REMOVAL OF CELLS FROM 8 THEIR NATIVE MICROENVIRONMENT, WITH THE MEASURED DIFFERENTIATION OUTPUTS REFLECTING POTENTIAL BUT NOT TRUE 9 ENDOGENOUS FUNCTIONALITY. SEVERAL STUDIES HAVE REVEALED DISCREPANCIES BETWEEN NATIVE AND TRANSPLANTATION- 10 BASED ASSESSMENTS OF HSPC FUNCTION, UNDERSCORING THE CRITICAL IMPORTANCE OF EXAMINING A CELL'S FUNCTION WITHIN 11 ITS NATIVE ENVIRONMENT. WE HAVE DEVELOPED SEVERAL TOOLS IN ZEBRAFISH THAT DISCRIMINATE HSC AND HSC- 12 INDEPENDENT PROGENITOR FUNCTIONS WITHIN THEIR ENDOGENOUS EMBRYONIC/LARVAL ENVIRONMENTS TO FILL THIS KNOWLEDGE 13 GAP. WE ARE NOW POSITIONED TO DEPLOY THE ADVANTAGES OF THE ZEBRAFISH MODEL TO IDENTIFY REGULATORS INFLUENCING 14 THE FORMATION AND FUNCTION OF DIFFERENT HSC/HSC-INDEPENDENT PROGENITOR SUBSETS. IN AIM 1, WE WILL TEST THE 15 HYPOTHESIS THAT THERE COULD BE UNEXPECTED CONNECTIONS AMONG HEMATOPOIETIC AND IMMUNE CELLS AND UNREALIZED 16 DIFFERENTIATION POTENTIALS OF HSC/HSC-INDEPENDENT PROGENITORS. WE WILL USE APPROACHES THAT ALLOW VISUALIZATION 17 AND TRANSCRIPTIONAL CHARACTERIZATION OF HSCS, HSC-INDEPENDENT PROGENITORS, AND THEIR PROGENY THROUGHOUT THE 18 ENTIRE ORGANISM. IN AIM 2, WE WILL TEST THE HYPOTHESIS THAT FUNCTIONAL DIFFERENCES BETWEEN HSCS, HSC- 19 INDEPENDENT PROGENITORS ARISE FROM THEIR DISTINCT SPATIOTEMPORAL ORIGINS AND VIA DISTINCT GENETIC REGULATION. WE 20 WILL UTILIZE TEMPORAL AND SPATIAL LINEAGE TRACING, WHOLE MOUNT IN SITU HYBRIDIZATION, IN VIVO GENETIC SCREENING, AND 21 OUR NEW NATIVE HEMATOPOIESIS FUNCTIONAL ASSAYS TO UNCOVER THE WHEN, WHERE, AND HOW UNIQUELY CONTROLLING THE 22 EMBRYONIC GENERATION OF HSCS, BUT NOT PROGENITORS. IN THIS PROJECT, WE WILL ADDRESS MANY UNRESOLVED QUESTIONS 23 RELATED TO HSC AND HSC-INDEPENDENT PROGENITORS ARISING DURING DEVELOPMENT INCLUDING THE DIFFERENTIATION 24 REPERTOIRE OF THEIR PROGENY, THE CONNECTIONS AMONG LYMPHOID AND MYELOID IMMUNE EFFECTORS FOUND THROUGHOUT 25 THE ORGANISM, AND THE PROGRAMS UNDERLYING THE FORMATION AND FUNCTIONS OF THE DIVERSE STEM AND PROGENITORS 26 ARISING EMBRYONICALLY. THIS WORK WILL PROVIDE FUNDAMENTAL KNOWLEDGE ON THE EARLY ESTABLISHMENT OF HEMATOPOIETIC 27 AND IMMUNE HIERARCHIES RELEVANT TO UNDERSTANDING IMMUNE DISORDERS AND FOR THE DIRECTED PRODUCTION OF HSC AND 28 HSC-INDEPENDENT PROGENITORS AND THEIR FUNCTIONALLY DISTINCT PROGENY FROM HUMAN PLURIPOTENT STEM CELL SOURCES 29 FOR TREATMENT OF A VARIETY OF DISORDERS.

Posted 7/23/24